Testing effectiveness (Phase 2)Study completedNCT00192764What this trial is testingHigh Dose CHOP in LymphomaWho this might be right forNon-Hodgkin's Lymphoma Rambam Health Care Campus 45
Testing effectiveness (Phase 2)Study completedNCT03003520What this trial is testingDurvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell LymphomaWho this might be right forLymphoma, Large B-Cell, Diffuse Celgene 46
Early research (Phase 1)Study completedNCT00217412What this trial is testingVorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaWho this might be right forChildhood Acute Promyelocytic Leukemia (M3)Childhood Atypical Teratoid/Rhabdoid TumorChildhood Burkitt Lymphoma+16 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00002003What this trial is testingPhase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic LymphomasWho this might be right forLymphoma, Non-HodgkinHIV Infections Lederle Laboratories
Not applicableStudy completedNCT00536601What this trial is testingHigh-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+56 more Roswell Park Cancer Institute 174
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Study completedNCT00059995What this trial is testingMDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00949117What this trial is testingCyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With CancerWho this might be right forLeukemiaLymphomaMalnutrition+3 more University of South Florida 9
Not applicableEnded earlyNCT02145039What this trial is testingReduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic DiseasesWho this might be right forAcute LeukemiasBurkitt's LymphomaChronic Myelogenous Leukemia Masonic Cancer Center, University of Minnesota 2
Testing effectiveness (Phase 2)UnknownNCT00008307What this trial is testingCombination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Herbert Irving Comprehensive Cancer Center 52
Early research (Phase 1)Looking for participantsNCT04318678What this trial is testingCD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)Who this might be right forAML/MDSB-ALLT-ALL+1 more St. Jude Children's Research Hospital 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652What this trial is testingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more National Cancer Institute (NCI) 13
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Early research (Phase 1)Active Not RecruitingNCT00710892What this trial is testingCASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide GeneWho this might be right forAcute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more Baylor College of Medicine 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02523040What this trial is testingLenalidomide for Adult Histiocyte DisordersWho this might be right forLangerhans Cell Histiocytosis (LCH)Histiocytoses Erdheim-chester DiseaseHistiocytic Sarcoma (HS) Dana-Farber Cancer Institute 12
Early research (Phase 1)Looking for participantsNCT06980116What this trial is testingDose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell MalignanciesWho this might be right forRelapsed or Refractory B-cell MalignanciesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Follicular Lymphoma (FL)+4 more Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 85
Testing effectiveness (Phase 2)Study completedNCT00002471What this trial is testingCombination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00014391What this trial is testingRibavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03599960What this trial is testingCombination Chemotherapy in Patients With Newly Diagnosed BPDCNWho this might be right forBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Centre Hospitalier Universitaire de Besancon 26